Table 1 Coagulation tests and dp-ucMGP... | American Society of Hematology

Table 1

Coagulation tests and dp-ucMGP concentration before and after treatment with K vitamins

	Baseline	After vitamin K1 (10 mg/day)*	After vitamin K1 (20 mg/day)†	Normal values	Hemostatic level (%)
Prothrombin activity (%)	11	36	42	70-100
Ratio of APTT	1.65	1.24	1.02	0.84-1.21
Factor II (%)	26	46	38	50-150	20-30
Factor VII (%)	<1	21	37	50-150	15-20
Factor IX (%)	12	53	54	50-150	10-40
Factor X (%)	13	27	31	50-150	15-20
Factor V (%)	80			50-150
Protein C (%)	7	13	21	70-140
Protein S (%)	10	6	8	60-120
dp-ucMGP (pM)	2387	2750	2407	32-546‡

	Baseline	After vitamin K1 (10 mg/day)*	After vitamin K1 (20 mg/day)†	Normal values	Hemostatic level (%)
Prothrombin activity (%)	11	36	42	70-100
Ratio of APTT	1.65	1.24	1.02	0.84-1.21
Factor II (%)	26	46	38	50-150	20-30
Factor VII (%)	<1	21	37	50-150	15-20
Factor IX (%)	12	53	54	50-150	10-40
Factor X (%)	13	27	31	50-150	15-20
Factor V (%)	80			50-150
Protein C (%)	7	13	21	70-140
Protein S (%)	10	6	8	60-120
dp-ucMGP (pM)	2387	2750	2407	32-546‡

Taking daily oral doses of 10 mg of vitamin K1 over 3 months.

Taking daily oral doses of 20 mg of vitamin K1 for more than 1 year, plus taking daily doses of 41 mg of MK-4 and 2 mg of MK-7 over 6 months.

Median value is 172.¹⁰